Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR.
The item "Ebitda-Per-Share" stands at 9.95 Euros as of 09/30/2025.
As of the end of Sanofi SA's third quarter, the item "Ebitda Per Share" stands at 9.95 EUR. This represents a decrease of -4.72 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.30 percent compared to the value the year prior.
The 1 year change in percent is 16.30.
The 3 year change in percent is -7.57.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebitda Per Share | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebitda Per Share | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebitda Per Share | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebitda Per Share | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebitda Per Share | 280,205,508,085.11 |